Hematopoietic Stem Cell Mobilization and Homing

Handbook of Stem Cells

Volumn 2, Issue , 2004, Pages 593-607

  Seggewiss, Ruth ^a   Dunbar, Cynthia E ^a   Orlic, Donald ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955010257     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012436643-5/50143-7     Document Type: Chapter

References (192)

1. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998, 125:725-732.
2. Yoder M.C., Hiatt K. Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 1997, 89:2176-2183.
3. Yoder M.C., Hiatt K., Dutt P., Mukherjee P., Bodine D.M., Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 1997, 7:335-344.
4. de Bruijn M.F., Speck N.A., Peeters M.C., Dzierzak E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 2000, 19:2465-2474.
5. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86:897-906.
6. Luckett W.P. Origin and differentiation of the yolk sac and extraembryonic mesoderm in presomite human and rhesus monkey embryos. Am. J. Anat. 1978, 152:59-97.
7. Tavian M., Coulombel L., Luton D., Clemente H.S., Dieterlen-Lievre F., Peault B. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 1996, 87:67-72.
8. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., Shaper J.H. Antigenic analysis of hematopoiesis: III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 1984, 133:157-165.
9. Ogawa M., Matsuzaki Y., Nishikawa S., Hayashi S., Kunisada T., Sudo T., Kina T., Nakauchi H. Expression and function of c-kit in hemopoietic progenitor cells. J. Exp. Med. 1991, 174:63-71.
10. Orlic D., Fischer R., Nishikawa S., Nienhuis A.W., Bodine D.M. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 1993, 82:762-770.
11. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 1988, 241:58-62.
12. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
13. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404:193-197.
14. Till J.E.M., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 1961, 14:1419-1430.
15. Wu A.M., Till J.E., Siminovitch L., McCulloch E.A. A cytological study of the capacity for differentiation of normal hemopoietic colony- forming cells. J. Cell Physiol. 1967, 69:177-184.
16. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000, 105:71-77.
17. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
18. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
19. Prockop D.J. Adult stem cells gradually come of age. Nat. Biotechnol. 2002, 20:791-792.
20. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisber A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
21. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945, 102:400-401.
22. Jacobson L.O., Marks E.K., Gaston E. Observations on the effect of spleen shielding and the injection of cell suspensions on survival following irradiation. Radiobiology Symposium 1955, 122-133. Academic Press, Totowa, NJ. Z.M.A. Bacq, P. Alexander (Eds.).
23. Tyler R.W., Everett N.B. A radioautographic study of hemopoietic repopulation using irradiated parabiotic rats: relation to the stem cell problem. Blood 1966, 28:872-890.
24. Goodman J.H., Hodgson G.S. Evidence for stem cells in the peripheral blood of mice. Blood 1962, 19:702-714.
25. McCredie K.B., Hersh E.M., Freireich E.J. Cells capable of colony formation in the peripheral blood of man. Science 1971, 171:293-294.
26. Goldman J.M., Catovsky D., Galton D.A. Reversal of blast-cell crisis in C.G.I. by transfusion of stored autologous buffy-coat cells. Lancet 1978, 1:437-438.
27. Goldman J.M., Catovsky D., Goolden A.W., Johnson S.A., Galton D.A. Buffy coat autografts for patients with chronic granulocytic leukaemia in transformation. Blut 1981, 42:149-155.
28. Juttner C.A., L.B.T., Haylock D.N., Branford A., Kimber R.J. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br. J. Haematol. 1985, 61:739-745.
29. Kessinger A., Armitage J.O., Landmark J.D., Weisenburger D.D. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp. Hematol. 1986, 14:192-196.
30. Korbling M., Dorken B., Ho A.D., Pezzutto A., Hunstein W., Fliedner T.M. Autologous transplantation of bloodderived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986, 67:529-532.
31. Reiffers J., Bernard P., David B., Vezon G., Sarrat A., Marit G., Moulinier J., Broustet A. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp. Hematol. 1986, 14:312-315.
32. Kessinger A. Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?. Stem Cells 1995, 13:351-354.
33. Dunbar C.E., Cottler-Fox M., O'Shaughnessy J.A., Doren S., Carter C., Berenson R., Brown S., Moen R.C., Greenblatt J., Stewart F.M. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995, 85:3048-3057.
34. Kessinger A., Smith D.M., Strandjord S.E., Landmark J.D., Dooley D.C., Law P., Coccia P.F., Warkentin P.I., Weisenburger D.D., Armitage J.O. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989, 4:643-646.
35. Bensinger W.I., Martin P.J., Storer B., Clift R., Forman S.J., Negrin R., Kashyap A., Flowers M.E., Lilleby K., Chauncey T.R., Storb R., Appelbaum F.R. Transplantation of bone marrow as compared with peripheralblood cells from HLA-identical relatives in patients with hematologic cancers. N. Engl. J. Med. 2001, 344:175-181.
36. To L.B., Haylock D.N., Simmons P.J., Juttner C.A. The biology and clinical uses of blood stem cells. Blood 1997, 89:2233-2258.
37. Goldman J.M., Horowitz M.M. The international bone marrow transplant registry. Int. J. Hematol. 2002, 76(Suppl 1):393-397.
38. Siena S., Bregni M., Brando B., Ravagnani F., Bonadonna G., Gianni A.M. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide- treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989, 74:1905-1914.
39. Craddock C.F., Apperley J.F., Wright E.G., Healy L.E., Bennett C.A., Evans M., Grimsley P.G., Gordon M.Y. Circulating stem cells in mice treated with cyclophosphamide. Blood 1992, 80:264-269.
40. Neben S., Marcus K., Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 1993, 81:1960-1967.
41. Morrison S.J., Wright D.E., Weissman I.L. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1908-1913.
42. Bodine D.M., Seidel N.E., Gale M.S., Nienhuis A.W., Orlic D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994, 84:1482-1491.
43. Wright D.E., Wagers A.J., Gulati A.P., Johnson F.L., Weissman I.L. Physiological migration of hematopoietic stem and progenitor cells. Science 2001, 294:1933-1936.
44. Abkowitz J.L., Robinson A.E., Kale S., Long M.W., Chen J. The mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood. 2003, 102:867-872.
45. Issarachai S., Priestley G.V., Nakamoto B., Papayannopoulou T. Cells with hemopoietic potential residing in muscle are itinerant bone marrow-derived cells. Exp. Hematol. 2002, 30:366-373.
46. Kawada H., Ogawa M. Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. Blood 2001, 98:2008-2013.
47. McKinney-Freeman S.L., Jackson K.A., Camargo F.D., Ferrari G., Mavilio F., Goodell M.A. Musclederived hematopoietic stem cells are hematopoietic in origin. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1341-1346.
48. Bodine D.M., Seidel N.E., Zsebo K.M., Orlic D. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 1993, 82:445-455.
49. Andrews R.G., Briddell R.A., Knitter G.H., Opie T., Bronsden M., Myerson D., Appelbaum F.R., McNiece I.K. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells. Blood 1994, 84:800-810.
50. Andrews R.G., Briddell R.A., Knitter G.H., Rowley S.D., Appelbaum F.R., McNiece I.K. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 1995, 85:15-20.
51. Orlic D., Girard L.J., Jordan C.T., Anderson S.M., Cline A.P., Bodine D.M. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11097-11102.
52. Mulligan R.C. The basic science of gene therapy. Science 1993, 260:926-932.
53. Horwitz M.E., Malech H.L., Anderson S.M., Girard L.J., Bodine D.M., Orlic D. Granulocyte colonystimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA. Exp. Hematol. 1999, 27:1160-1167.
54. Kim H.J., Tisdale J.F., Wu T., Takatoku M., Sellers S.E., Zickler P., Metzger M.E., Agricola B.A., Malley J.D., Kato I., Donahue R.E., Brown K.E., Dunbar C.E. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood 2000, 96:1-8.
55. Wu T., Kim H.J., Sellers S.E., Meade K.E., Agricola B.A., Metzger M.E., Kato I., Donahue R.E., Dunbar C.E., Tisdale J.F. Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods. Mol. Ther. 2000, 1:285-293.
56. Hematti P., Sellers S.E., Agricola B.A., Metzger M.E., Donahue R.E., Dunbar C.E. Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates. Blood 2003, 101:2199-2205.
57. Laterveer L., Lindley I.J., Hamilton M.S., Willemze R., Fibbe W.E. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and longterm myelolymphoid repopulating ability. Blood 1995, 85:2269-2275.
58. Laterveer L., Lindley I.J., Heemskerk D.P., Camps J.A., Pauwels E.K., Willemze R., Fibbe W.E. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996, 87:781-788.
59. Corre I., Pineau D., Hermouet S. Interleukin-8: an autocrine/paracrine growth factor for human hematopoietic progenitors acting in synergy with colony stimulating factor-1 to promote monocyte-macrophage growth and differentiation. Exp. Hematol. 1999, 27:28-36.
60. Vetillard J., Drouet M., Neildez-Nguyen T.M., Mestries J.C., Mathieu J., Thierry D., Herodin F. Interleukine-8 acts as a strong peripheral blood granulocyte-recruiting agent rather than as a hematopoietic progenitor cell-mobilizing factor. J. Hematother. Stem Cell Res. 1999, 8:365-379.
61. Pruijt J.F., Verzaal P., van Os R., de Kruijf E.J., van Schie M.L., Mantovani A., Vecchi A., Lindley I.J., Willemze R., Starckx S., Opdenakker G., Fibbe W.E. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6228-6233.
62. Gong J.K. Endosteal marrow: a rich source of hematopoietic stem cells. Science 1978, 199:1443-1445.
63. Yoder M.C., Williams D.A. Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol. 1995, 23:961-967.
64. Verfaillie C.M. Adhesion receptors as regulators of the hematopoietic process. Blood 1998, 92:2609-2612.
65. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science 1996, 272:60-66.
66. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
67. Krause D.S. Plasticity of marrow-derived stem cells. Gene Ther. 2002, 9:754-758.
68. Lemischka I. A few thoughts about the plasticity of stem cells. Exp. Hematol. 2002, 30:848-852.
69. Tisdale J.F., Dunbar C.E. Plasticity and hematopoiesis: Circe's transforming potion? Curr. Opin. Hematol. 2002, 9:268-273.
70. Velders G.A., Van Os R., Hagoort H., Versaal P., Guiot H.F., Lindley I.J., Willemze R., Opdenakker G., Fibbe W.E. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood 2004, 103:340-346.
71. Campbell F.R. Ultrastructural studies of transmural migration of blood cells in the bone marrow of rats,mice and guinea pigs. Am. J. Anat. 1972, 135:521-535.
72. Weiss L. Transmural cellular passage in vascular sinuses of rat bone marrow. Blood 1970, 36:189-208.
73. Ma Q., Jones D., Springer T.A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999, 10:463-471.
74. Mohle R., Moore M.A., Nachman R.L., Rafii S. Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study usinga human bone marrow endothelial cell line. Blood 1997, 89:72-80.
75. van der Loo J.C., Xiao X., McMillin D., Hashino K., Kato I., Williams D.A. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J. Clin. Invest. 1998, 102:1051-1061.
76. Nilsson S.K., Johnston H.M., Coverdale J.A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001, 97:2293-2299.
77. Edinger M., Cao Y.A., Verneris M.R., Bachmann M.H., Contag C.H., Negrin R.S. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003, 101:640-648.
78. Hinds K.A., Hill J.M., Shapiro E.M., Laukkanen M.O., Silva A.C., Combs C.A., Varney T.R., Balaban R.S., Koretsky A.P., Dunbar C.E. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003, 102:867-872.
79. Cashman J.D., Eaves C.J. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000, 96:3979-3981.
80. van Hennik P.B., de Koning A.E., Ploemacher R.E. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999, 94:3055-3061.
81. Cui J., Wahl R.L., Shen T., Fisher S.J., Recker E., Ginsburg D., Long M.W. Bone marrow cell trafficking following intravenous administration. Br. J. Haematol. 1999, 107:895-902.
82. Jetmore A., Plett P.A., Tong X., Wolber F.M., Breese R., Abonour R., Orschell-Traycoff C.M., Srour E.F. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 2002, 99:1585-1593.
83. Wang J., Kimura T., Asada R., Harada S., Yokota S., Kawamoto Y., Fujimura Y., Tsuji T., Ikehara S., andSonoda Y. SCID-repopulating cell activity of human cord bloodderived CD34- cells assured by intra- bone marrow injection. Blood 2003, 101:2924-2931.
84. Yahata T., Ando K., Sato T., Miyatake H., Nakamura Y., Muguruma Y., Kato S., Hotta T. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003, 101:2905-2913.
85. Simmons P.J., Masinovsky B., Longenecker B.M., Berenson R., Torok-Storb B., Gallatin W.M. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992, 80:388-395.
86. Hurley R.W., McCarthy J.B., Verfaillie C.M. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J. Clin. Invest. 1995, 96:511-519.
87. Takatoku M., Sellers S., Agricola B.A., Metzger M.E., Kato I., Donahue R.E., Dunbar C.E. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J. Clin. Invest. 2001, 108:447-455.
88. Papayannopoulou T., Craddock C., Nakamoto B., Priestley G.V., Wolf N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9647-9651.
89. Papayannopoulou T., Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9374-9378.
90. Vermeulen M., Le Pesteur F., Gagnerault M.C., Mary J.Y., Sainteny F., Lepault F. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998, 92:894-900.
91. Papayannopoulou T., Priestley G.V., Nakamoto B. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood 1998, 91:2231-2239.
92. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., Scott L.M., Harlan J.M. Synergistic mobilization of hemopoietic progenitor cells using concurrent beta1 and beta2 integrin blockade or beta2-deficient mice. Blood 2001, 97:1282-1288.
93. Bellucci R., De Propris M.S., Buccisano F., Lisci A., Leone G., Tabilio A., de Fabritiis P. Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF. Bone Marrow Transplant 1999, 23:1-8.
94. Dercksen M.W., Gerritsen W.R., Rodenhuis S., Dirkson M.K., Slaper-Cortenbach I.C., Schaasberg W.P., Pinedo H.M., von dem Borne A.E., van der Schoot C.E. Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 1995, 85:3313-3319.
95. Prosper F., Stroncek D., McCarthy J.B., Verfaillie C.M. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function. J. Clin. Invest. 1998, 101:2456-2467.
96. Watanabe T., Dave B., Heimann D.G., Lethaby E., Kessinger A., Talmadge J.E. GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cellsin adhesion molecule expression. Bone Marrow Transplant 1997, 19:1175-1181.
97. Gazitt Y., Liu Q. Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem Cells 2001, 19:37-45.
98. Levesque J.P., Takamatsu Y., Nilsson S.K., Haylock D.N., Simmons P.J. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001, 98:1289-1297.
99. Williams D.A., Rios M., Stephens C., Patel V.P. Fibronectin and VLA-4 in haematopoietic stem cellmicroenvironment interactions. Nature 1991, 352:438-441.
100. Hirsch E., Iglesias A., Potocnik A.J., Hartmann U., Fassler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1integrins. Nature 1996, 380:171-175.
101. Potocnik A.J., Brakebusch C., Fassler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetalliver, spleen, and bone marrow. Immunity 2000, 12:653-663.
102. Lapidot T., Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002, 16:1992-2003.
103. Plett P.A., Frankovitz S.M., Wolber F.M., Abonour R., Orschell-Traycoff C.M. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential. Exp. Hematol. 2002, 30:1061-1069.
104. Szilvassy S.J., Meyerrose T.E., Ragland P.L., Grimes B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 2001, 98:2108-2115.
105. Spencer A., Jackson J., Baulch-Brown C. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation. Bone Marrow Transplant 2001, 28:1019-1022.
106. Pilarski L.M., Pruski E., Wizniak J., Paine D., Seeberger K., Mant M.J., Brown C.B., Belch A.R. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Blood 1999, 93:2918-2927.
107. Dimitroff C.J., Lee J.Y., Rafii S., Fuhlbrigge R.C., Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 2001, 153:1277-1286.
108. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., Mak T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997, 90:2217-2233.
109. Frenette P.S., Mayadas T.N., Rayburn H., Hynes R.O., Wagner D.D. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996, 84:563-574.
110. Frenette P.S., Subbarao S., Mazo I.B., von Andrian U.H., Wagner D.D. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14423-14428.
111. Frenette P.S., Weiss L. Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms. Blood 2000, 96:2460-2468.
112. Sweeney E.A., Priestley G.V., Nakamoto B., Collins R.G., Beaudet A.L., Papayannopoulou T. Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6544-6549.
113. Russell E.S. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 1979, 20:357-459.
114. Chabot B., Stephenson D.A., Chapman V.M., Besmer P., Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouseW locus. Nature 1988, 335:88-89.
115. Huang E., Nocka K., Beier D.R., Chu T.Y., Buck J., Lahm H.W., Wellner D., Leder P., Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990, 63:225-233.
116. Brannan C.I., Lyman S.D., Williams D.E., Eisenman J., Anderson D.M., Cosman D., Bedell M.A., Jenkins N.A., Copeland N.G. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:4671-4674.
117. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., Crystal R.G., Besmer P., Lyden D., Moore M.A., Werb Z., Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
118. Aiuti A., Webb I.J., Bleul C., Springer T., Gutierrez-Ramos J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 1997, 185:111-120.
119. Nagasawa T., Kikutani H., Kishimoto T. Molecular cloning and structure of a pre-B-cell growthstimulating factor. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2305-2309.
120. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins. Science 1993, 261:600-603.
121. Wright D.E., Bowman E.P., Wagers A.J., Butcher E.C., Weissman I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 2002, 195:1145-1154.
122. Kim C.H., Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 1998, 91:100-110.
123. Peled A., Grabovsky V., Habler L., Sandbank J., Arenzana-Seisdedos F., Petit I., Ben-Hur H., Lapidot T., Alon R. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J. Clin. Invest. 1999, 104:1199-1211.
124. Peled A., Kollet O., Ponomaryov T., Petit I., Franitza S., Grabovsky V., Slav M.M., Nagler A., Lider O., Alon R., Zipori D., Lapidot T. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000, 95:3289-3296.
125. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
126. Mohle R., Bautz F., Rafii S., Moore M.A., Brugger W., Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cellderived factor-1. Blood 1998, 91:4523-4530.
127. Kawabata K., Ujikawa M., Egawa T., Kawamoto H., Tachibana K., Iizasa H., Katsura Y., Kishimoto T., Nagasawa T. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5663-5667.
128. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
129. Kollet O., Petit I., Kahn J., Samira S., Dar A., Peled A., Deutsch V., Gunetti M., Piacibello W., Nagler A., Lapidot T. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood 2002, 100:2778-2786.
130. Rosu-Myles M., Gallacher L., Murdoch B., Hess D.A., Keeney M., Kelvin D., Dale L., Ferguson S.S., Wu D., Fellows F., Bhatia M. The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14626-14631.
131. Kollet O., Spiegel A., Dar A., Samira S., Chen Y., Shafritz D., Suriawinata J., Thung S., Seis-Dedos F., Nagler A., Revel M., Lapidot T. Involvement of SDF-1/CXCR4 Interactions in the migration of immature human CD34+ cells into the liver of transplanted NOD/SCID mice. Blood 2001, 98:2297a.
132. Sawada S., Gowrishankar K., Kitamura R., Suzuki M., Suzuki G., Tahara S., Koito A. Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. J. Exp. Med. 1998, 187:1439-1449.
133. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., Ponomaryov T., Taichman R.S., Arenzana-Seisdedos F., Fujii N., Sandbank J., Zipori D., Lapidot T. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 2002, 3:687-694.
134. Gazitt Y., Shaughnessy P., Liu Q. Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors. Stem Cells 2001, 19:134-143.
135. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 2002, 30:973-981.
136. Liu F., Wu H.Y., Wesselschmidt R., Kornaga T., Link D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony- stimulating factor receptordeficient mice. Immunity 1996, 5:491-501.
137. Liu F., Poursine-Laurent J., Link D.C. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood 1997, 90:2522-2528.
138. Levesque J.P., Bendall L.J., Hendy J., Takamatsu Y., Simmons P.J. Neutrophil enzymes degrade CXCR4 on CD34+ progenitors: Implications for progenitor cell mobilization. Blood 2002, 100:107a.
139. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 2003, 111:187-196.
140. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
141. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 1997, 89:1260-1270.
142. Stetler-Stevenson W.G., Hewitt R., Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 1996, 7:147-154.
143. Stetler-Stevenson W.G., Yu A.E. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 2001, 11:143-152.
144. Fibbe W.E., Pruijt J.F., van Kooyk Y., Figdor C.G., Opdenakker G., Willemze R. The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization. Semin. Hematol. 2000, 37:19-24.
145. Pruijt J.F., Fibbe W.E., Laterveer L., Pieters R.A., Lindley I.J., Paemen L., Masure S., Willemze R., Opdenakker G. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10863-10868.
146. Borregaard N., Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89:3503-3521.
147. Masure S., Proost P., VanDamme J., Opdenakker G. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 1991, 198:391-398.
148. Janowska-Wieczorek A., Marquez L.A., Dobrowsky A., Ratajczak M.Z., Cabuhat M.L. Differential MMP and TIMP production by human marrow f126.and peripheral blood CD34(+) cellsin response to chemokines. Exp. Hematol. 2000, 28:1274-1285.
149. Ries C., Petrides P.E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe Seyler 1995, 376:345-355.
150. Janowska-Wieczorek A., Marquez L.A., Nabholtz J.M., Cabuhat M.L., Montano J., Chang H., Rozmus J., Russell J.A., Edwards D.R., Turner A.R. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cellsand their transmigration through reconstituted basement membrane. Blood 1999, 93:3379-3390.
151. Levesque J.P., Liu F., Simmons P.J., Betsuyaku T., Senior R., Pham C., Link D.C. Characterization of hematopoietic progenitor mobilization in protease deficient mice. Blood March 9 Epub 2004, (in press).
152. Anderson D.J., Gage F.H., Weissman I.L. Can stem cells cross lineage boundaries?. Nat. Med. 2001, 7:393-395.
153. Blau H.M., Brazelton T.R., Weimann J.M. The evolving concept of a stem cell:Entity or function?. Cell 2001, 105:829-841.
154. Graf T., Differentiation plasticity of hematopoietic cells. Blood 2002, 99:3089-3101.
155. Wells W.A. Is transdifferentiation in trouble?. J. Cell Biol. 2002, 157:15-18.
156. Korbling M., Katz R.L., Khanna A., Ruifrok A.C., Rondon G., Albitar M., Champlin R.E., Estrov Z. Hepatocytes and epithelial cells of donor origin in recipients of peripheralblood stem cells. N. Engl. J. Med. 2002, 346:738-746.
157. Weimann J.M., Charlton C.A., Brazelton T.R., Hackman R.C., Blau H.M. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2088-2093.
158. Deb A., Wang S., Skelding K.A., Miller D., Simper D., Caplice N.M. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003, 107:1247-1249.
159. Okamoto R., Yajima T., Yamazaki M., Kanai T., Mukai M., Okamoto S., Ikeda Y., Hibi T., Inazawa J., Watanabe M. Damaged epithelia regenerated by bone marrowderived cells in the human gastrointestinal tract. Nat. Med. 2002, 8:1011-1017.
160. Theise N.D., Nimmakayalu M., Gardner R., Illei P.B., Morgan G., Teperman L., Henegariu O., Krause D.S. Liver from bone marrow in humans. Hepatology 2000, 32:11-16.
161. Laflamme M.A., Myerson D., Saffitz J.E., Murry C.E. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 2002, 90:634-640.
162. Muller P., Pfeiffer P., Koglin J., Schafers H.J., Seeland U., Janzen I., Urbschat S., Bohm M. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002, 106:31-35.
163. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Chimerism of the transplanted heart. N. Engl. J. Med. 2002, 346:5-15.
164. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416:542-545.
165. Vassilopoulos G., Wang P.R., Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422:901-904.
166. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Olson S., Grompe M. Cell fusion is the principal source of bonemarrow-derived hepatocytes. Nature 2003, 422:897-901.
167. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., Wang X., Finegold M., Weissman I.L., Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6:1229-1234.
168. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10344-10349.
169. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K., Goodell M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 2001, 107:1395-1402.
170. Lanza R., Moore M.A., Wakayama T., Perry A.C., Shieh J.H., Hendrikx J., Leri A., Chimenti S., Monsen A., Nurzynska D., West M.D., Kajstura J., Anversa P. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ. Res. 2004, 94:820-827.
171. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
172. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
173. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes, and hepatocytes. Nature 2003, 425:968-973.
174. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., Neutzel S., Sharkis S.J. Multi-organ, multi-lineage engraftment by a single bone marrowderived stem cell. Cell 2001, 105:369-377.
175. Grant M.B., May W.S., Caballero S., Brown G.A., Guthrie S.M., Mames R.N., Byrne B.J., Vaught T., Spoerri P.E., Peck A.B., Scott E.W. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002, 8:607-612.
176. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
177. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
178. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106:3009-3017.
179. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
180. Hasegawa M., Baldwin T.M., Metcalf D., Foote S.J. Progenitor cell mobilization by granulocyte colonystimulating factor controlled by loci on chromosomes 2 and 11. Blood 2000, 95:1872-1874.
181. de Haan G., Bystrykh L.V., Weersing E., Dontje B., Geiger H., Ivanova N., Lemischka I.R., Vellenga E., Van Zant G. A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood 2002, 100:2056-2062.
182. Geiger H., True J.M., de Haan G., Van Zant G. Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy. Blood 2001, 98:2966-2972.
183. Benboubker L., Watier H., Carion A., Georget M.T., Desbois I., Colombat P., Bardos P., Binet C., Domenech J. Association between the SDF1-3A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br. J. Haematol. 2001, 113:247-250.
184. Geiger H., Van Zant G. The aging of lymphohematopoietic stem cells. Nat. Immunol. 2002, 3:329-333.
185. De Clercq E., Yamamoto N., Pauwels R., Balzarini J., Witvrouw M., De Vreese K., Debyser Z., Rosenwirth B., Peichl P., Datema R., Thornton D., Skerlj R., Gaul F., Padmanabhan S., Bridger G., Henson G., Abrams M. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 1994, 38:668-674.
186. De Vreese K., Reymen D., Griffin P., Steinkasserer A., Werner G., Bridger G.J., Este J., James W., Henson G.W., Desmyter J., Anne J., De Clercq I. The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entryafter binding. Antiviral Res. 1996, 29:209-219.
187. Hatse S., Princen K., Bridger G., De Clercq E., Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 2002, 527:255-262.
188. Hendrix C.W., Flexner C., MacFarland R.T., Giandomenico C., Fuchs E.J., Redpath E., Bridger G., Henson G.W. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 2000, 44:1667-1673.
189. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hubel K., Cooper S., Hangoc G., Bridger G.J., Henson G.W., Calandra G., Dale D.C. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003, 102:2728-2730.
190. Devine S.M., Flomenberg N., Vesole D.H., Liesvold J., Weisdorf D., Badel K., Calandra G., Dipersio J.F. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J. Clin. Oncol. 2004, 22:95-102.
191. King A.G., Horowitz D., Dillon S.B., Levin R., Farese A.M., Macvittie T.J., Pelus L.M. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood 2001, 97:1534-1542.
192. Pelus L.M., Bian H., King A.G., Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT/CXCL2δ4. Blood 2004, 1(103):110-119.